August 2022

Dartisla ODT From Edenbridge Pharmaceuticals

August 26, 2022

The FDA has approved glycopyrrolate orally disintegrating tablets (Dartisla ODT; Edenbridge Pharmaceuticals) to reduce symptoms of peptic ulcer as an adjunct to peptic ulcer treatment in adults.